Clinical Trials Related to Shanghai Henlius Biotech

Related studies linked through entity extraction aliases.

Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors

Status: UNKNOWN
Phase: PHASE1

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors

Status: UNKNOWN
Phase: PHASE1

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

Status: WITHDRAWN
Phase: PHASE1

Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor

Status: COMPLETED
Phase: PHASE1

A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma

Status: UNKNOWN
Phase: PHASE1/PHASE2

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Status: UNKNOWN
Phase: PHASE1

HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors

Status: UNKNOWN
Phase: PHASE1

A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer

Status: UNKNOWN
Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Status: COMPLETED
Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma

Status: UNKNOWN
Phase: PHASE2

HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer

Status: UNKNOWN
Phase: PHASE2

Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC

Status: NOT_YET_RECRUITING
Phase: PHASE2

The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

Status: UNKNOWN
Phase: PHASE2

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC

Status: UNKNOWN
Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of HLX07 in nsqNSCLC Patients With High EGFR Expression

Status: UNKNOWN
Phase: PHASE2